Careology and Entia join forces to transform cancer care

Collaboration brings remote care to cancer patients

Careology and Entia have announced a partnership to enhance cancer care through innovative digital and at-home solutions. The collaboration aims to empower patients to self-manage aspects of their treatment and reduce hospital reliance.

Entia’s Liberty, an at-home blood monitoring solution, will integrate with Careology’s platform. This allows patients to conduct blood tests at home for their clinicians to monitor treatment responses remotely. Such tools alleviate routine patient assessments and support personalised, preventative care pathways.

Careology’s platform supports patients and cancer care teams across the UK and US. It provides tools for managing symptoms, medication schedules, and holistic supportive care, enabling early interventions and care closer to home.

Paul Landau, Founder and CEO of Careology, says: “We are excited to work closely with Entia to continue enhancing the cancer care experience in a truly patient-centric manner. By providing patients with self-service tools, they feel less restricted by treatment and allow their cancer teams to monitor progress remotely, enabling oversight and early intervention.”

Entia’s Liberty includes the UK-approved at-home full blood count analyser, developed in collaboration with leading oncology centres. Dr Toby Basey-Fisher, Founder and CEO of Entia, says: “This collaboration marks a significant step forward in patient empowerment, allowing individuals to manage their health with greater ease and autonomy.”

By integrating data such as heart rate and medication patterns, the partnership provides comprehensive insights for clinicians. This combined effort is set to revolutionise cancer care, easing pressures on health systems and optimising patient outcomes.